Newsome et al. evaluated the FibroScan-AST (FAST) score in identifying MASH patients that combined liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) from the FibroScan® with the lab test aspartate aminotransferase (AST): alanine aminotransferase (AST:ALT) ratio20. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.